Search
Search results (15)
Knowledge center
Webinars by Pelago
Pelago Bioscience is a Drug Discovery Research Partner supporting preclinical and clinical drug discovery and development. The core of our service is the patented Cellular Thermal Shift Assay (CETSA®) and complementary functional and proteomics assays.CETSA®, unlike other solutions on...
Scientific publication
Mechanism of Action for Degraders
Targeted protein degradation is a novel modality with the potential to tackle therapeutically interesting proteins beyond the limitations of current existing approaches. In this area, CETSA® is a powerful technology which can be applied for investigating the degradation target...
Knowledge center
Compound Evaluation and Potency Ranking
It is a well-established fact in basic science, as well as in drug discovery, that the differences between an assay based on a purified or recombinant protein and a full-length protein in a native cellular context may have substantial impact on the data. This will...
Knowledge center
Target Deconvolution
Since the protein targets of any given compound hit from a phenotypic screen are initially unknown, one major challenge with phenotypic-based drug discovery is the need for target identification or deconvolution. Choosing the most efficient and reliable method for...
Knowledge center
Hit Confirmation
As a cellular target engagement assay that determines the level of interaction between a ligand and a target protein of interest in a physiologically relevant setting, CETSA® is perfectly suited for hit confirmation. CETSA® requires no protein or ligand modifications...
Knowledge center
Target Engagement
For a drug to be effective according to the target hypothesis, it must selectively bind to the intended target protein to elicit its effect. Target engagement (TE) is defined as the interaction of ligands with their molecular targets. Assessment of a compound’s TE is...
Knowledge center
Biomarker Discovery
Biomarkers are important to facilitate translation, validate the therapeutic hypothesis and monitor therapeutic effect in clinical trials and beyond. The identification of biomarkers is a time-demanding but crucial part of the preclinical drug discovery...
Knowledge center
CETSA® on Membrane Proteins
CETSA® has primarily been applied to soluble proteins which, upon heating, denaturate to form insoluble aggregates by exposing hydrophobic surfaces. Nevertheless, CETSA® has successfully been applied to a number of membrane-associated proteins including...
Knowledge center
Preclinical Development
In late-stage lead optimization, before CD selection, a smaller set of compounds are further investigated. The aim here is to ensure that the CD (or CDs) ultimately selected is safe for clinical testing as well as suitable for formulation and that other pre-clinical drug...
Knowledge center
Lead Optimization
The aim at this stage of the drug discovery and development process is to optimize the compound properties to ensure the development of safe and effective candidate drugs (CDs) that can be dosed in healthy volunteers. Structure-activity relationship (SAR) analysis is used for guidance...
Knowledge center
Selectivity
In drug discovery, selective binding of the compound to the right target is important for the drug to be both effective and safe. To achieve this, the drug must be present at the site of action and occupy the intended target...
Knowledge center
Target Validation
Reliable data probing the disease-related hypothesis for a potential therapeutic target is crucial throughout the drug discovery and development process. The ultimate target validation is not achieved until the proof-of-concept study in phase 2 patient...
Knowledge center
Library Screening
CETSA® can determine cellular target engagement in physiologically relevant settings of the native, full-length protein and can potentially unlock novel chemical space. CETSA® library screening in intact cells gives direct confirmation on target engagement of your...
Knowledge center
When would you like to know if your Compound really is Therapeutic?
Early discovery or late confirmation? Proteomic-wide profiling or a few carefully selected targets? Both approaches are important tools in drug discovery. But it turns out that the choice between a broad and narrow scope is often driven by non-scientific factors...
Knowledge center
Translational studies
CETSA® can assess target engagement across a multitude of sample types. Established assays can easily be transferred from cell line to animal tissue, human primary cells, or patient-derived material, and thereby be used for translation all the way from lab bench...